Ruxolitinib for steroid-refractory graft versus host disease in pediatric HSCT: high response rate and manageable toxicityYasmina Mozo, Beatriz Ruz-Caracuel, David Bueno et al.|Pediatric Hematology and Oncology|2021Cited by 28
Voriconazole Use in Children: Therapeutic Drug Monitoring and Control of Inflammation as Key Points for Optimal TreatmentJosé María Valle-T-Figueras, Pere Soler‐Palacín, Berta Renedo et al.|Journal of Fungi|2021Cited by 19
Isavuconazole use and TDM in real-world pediatric practiceBerta Fernández Ledesma, Pere Soler‐Palacín, Berta Renedo et al.|Antimicrobial Agents and Chemotherapy|2023Cited by 16
Low-dose liposomal amphotericin B for antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell transplantationNatalia Mendoza‐Palomar, Cristina Díaz de Heredia, Elena Soques et al.|Journal of Antimicrobial Chemotherapy|2020Cited by 16
Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)María Isabel Benítez‐Carabante, Cristina Díaz de Heredia, David Bueno et al.|Transplantation and Cellular Therapy|2024Cited by 13